Kehlet H, Dahl JB: The value of “multimodal” or “balanced analgesia” in postoperative pain treatment. .Anesth Analg 77::1048. ,1993. .

• PubMed
Kehlet H, Dahl JB: The value of “multimodal” or “balanced analgesia” in postoperative pain treatment. .Anesth Analg77::1048. ,1993. .8105724)| false
• Search Google Scholar
• Export Citation

Bannwarth B: Risk-benefit assessment of opioids in chronic noncancer pain. .Drug Saf 21::283. ,1999. .

• PubMed
Bannwarth B: Risk-benefit assessment of opioids in chronic noncancer pain. .Drug Saf21::283. ,1999. .10514020)| false
• Search Google Scholar
• Export Citation

Gabriel SE, Jaakkimainen L, Bombardier C: Risk for serious gastrointestinal complications related to use of non-steroidal anti-inflammatory drugs: a meta-analysis. .Ann Intern Med 115::787. ,1991. .

• PubMed
Gabriel SE, Jaakkimainen L, Bombardier C: Risk for serious gastrointestinal complications related to use of non-steroidal anti-inflammatory drugs: a meta-analysis. .Ann Intern Med115::787. ,1991. .1834002)| false
• Search Google Scholar
• Export Citation

Gajraj NM: Cyclooxygenase-2 inhibitors. .Anesth Analg 96::1720. ,2003. .

• PubMed
Gajraj NM: Cyclooxygenase-2 inhibitors. .Anesth Analg96::1720. ,2003. .12761004)| false
• Search Google Scholar
• Export Citation

Garcia Rodriguez LA, Jick H: Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. .Lancet 343::769. ,1994. .

• PubMed
Garcia Rodriguez LA, Jick H: Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. .Lancet343::769. ,1994. .7907735)| false
• Search Google Scholar
• Export Citation

Goldstein JL, Silverstein FE, Agrawal NM, et al: Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor. .Am J Gastroenterol 95::1681. ,2000. .

• PubMed
Goldstein JL, Silverstein FE, Agrawal NM, et al: Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor. .Am J Gastroenterol95::1681. ,2000. .10925968)| false
• Search Google Scholar
• Export Citation

Harris SI, Kuss M, Hubbard RC, et al: Upper gastrointestinal safety evaluation of parecoxib sodium, a new parenteral cyclooxygenase-2-specific inhibitor, compared with ketorolac, naproxen, and placebo. .Clin Ther 23::1422. ,2001. .

• PubMed
Harris SI, Kuss M, Hubbard RC, et al: Upper gastrointestinal safety evaluation of parecoxib sodium, a new parenteral cyclooxygenase-2-specific inhibitor, compared with ketorolac, naproxen, and placebo. .Clin Ther23::1422. ,2001. .11589257)| false
• Search Google Scholar
• Export Citation

Kivitz A, Eisen G, Zhao WW, et al: Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis. .J Fam Pract 51::530. ,2002. .

• PubMed
Kivitz A, Eisen G, Zhao WW, et al: Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis. .J Fam Pract51::530. ,2002. .12100776)| false
• Search Google Scholar
• Export Citation

Sikes DH, Agrawal NM, Zhao WW, et al: Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis. .Eur J Gastroenterol Hepatol 14::1101. ,2002. .

• PubMed
Sikes DH, Agrawal NM, Zhao WW, et al: Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis. .Eur J Gastroenterol Hepatol14::1101. ,2002. .12362101)| false
• Search Google Scholar
• Export Citation

Noveck RJ, Laurent A, Kuss M, et al: Parecoxib sodium does not impair platelet function in healthy elderly and non-elderly individuals: two randomised, controlled trials. .Clin Drug Invest 21::465. ,2001. .

• PubMed
Noveck RJ, Laurent A, Kuss M, et al: Parecoxib sodium does not impair platelet function in healthy elderly and non-elderly individuals: two randomised, controlled trials. .Clin Drug Invest21::465. ,2001. .)| false
• Search Google Scholar
• Export Citation

Leese PT, Talwalker S, Kent JD, et al: Valdecoxib does not impair platelet function. .Am J Emerg Med 20::275. ,2002. .

• PubMed
Leese PT, Talwalker S, Kent JD, et al: Valdecoxib does not impair platelet function. .Am J Emerg Med20::275. ,2002. .12098171)| false
• Search Google Scholar
• Export Citation

Leese PT, Recker DP, Kent JD: The COX-2 selective inhibitor, valdecoxib, does not impair platelet function in the elderly: results of a randomized controlled trial. .J Clin Pharmacol 43::504. ,2003. .

• PubMed
Leese PT, Recker DP, Kent JD: The COX-2 selective inhibitor, valdecoxib, does not impair platelet function in the elderly: results of a randomized controlled trial. .J Clin Pharmacol43::504. ,2003. .12751271)| false
• Search Google Scholar
• Export Citation

Broom DC, Samad TA, Kohno T, et al: Cyclooxygenase 2 expression in the spared nerve injury model of neuropathic pain. .Neuroscience 124::891. ,2004. .

• PubMed
Broom DC, Samad TA, Kohno T, et al: Cyclooxygenase 2 expression in the spared nerve injury model of neuropathic pain. .Neuroscience124::891. ,2004. .15026129)| false
• Search Google Scholar
• Export Citation

Samad TA, Moore KA, Sapirstein A, et al: Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity [letter]. .Nature 410::471. ,2001. .

• PubMed
Samad TA, Moore KA, Sapirstein A, et al: Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity [letter]. .Nature410::471. ,2001. .11260714)| false
• Search Google Scholar
• Export Citation

Woolf CJ, Costigan M: Transcriptional and posttranslational plasticity and the generation of inflammatory pain. .Proc Natl Acad Sci U S A 96::7723. ,1999. .

• PubMed
Woolf CJ, Costigan M: Transcriptional and posttranslational plasticity and the generation of inflammatory pain. .Proc Natl Acad Sci U S A96::7723. ,1999. .10393888)| false
• Search Google Scholar
• Export Citation

Woolf CJ, Salter MW: Neuronal plasticity: increasing the gain in pain. .Science 288::1765. ,2000. .

• PubMed
Woolf CJ, Salter MW: Neuronal plasticity: increasing the gain in pain. .Science288::1765. ,2000. .10846153)| false
• Search Google Scholar
• Export Citation

Woolf CJ, Mannion RJ: Neuropathic pain: aetiology, symptoms, mechanisms, and management. .Lancet 353::1959. ,1999. .

• PubMed
Woolf CJ, Mannion RJ: Neuropathic pain: aetiology, symptoms, mechanisms, and management. .Lancet353::1959. ,1999. .10371588)| false
• Search Google Scholar
• Export Citation

Neumann S, Doubell TP, Leslie T, et al: Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. .Nature 384::360. ,1996. .

• PubMed
Neumann S, Doubell TP, Leslie T, et al: Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. .Nature384::360. ,1996. .8934522)| false
• Search Google Scholar
• Export Citation

Seibert K, Zhang Y, Leahy K, et al: Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. .Proc Natl Acad Sci U S A 91::12013. ,1994. .

• PubMed
Seibert K, Zhang Y, Leahy K, et al: Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. .Proc Natl Acad Sci U S A91::12013. ,1994. .7991575)| false
• Search Google Scholar
• Export Citation

Hay C, de Belleroche J: Carrageenan-induced hyperalgesia is associated with increased cyclooxygenase-2 expression in spinal cord. .Neuroreport 8::1249. ,1997. .

• PubMed
Hay C, de Belleroche J: Carrageenan-induced hyperalgesia is associated with increased cyclooxygenase-2 expression in spinal cord. .Neuroreport8::1249. ,1997. .9175123)| false
• Search Google Scholar
• Export Citation

Desjardins PJ, Shu VS, Recker DP, et al: A single preoperative oral dose of valdecoxib, a new cyclooxygenase-2 specific inhibitor, relieves post-oral surgery or bunionectomy pain. .Anesthesiology 97::565. ,2002. .

• PubMed
Desjardins PJ, Shu VS, Recker DP, et al: A single preoperative oral dose of valdecoxib, a new cyclooxygenase-2 specific inhibitor, relieves post-oral surgery or bunionectomy pain. .Anesthesiology97::565. ,2002. .12218521)| false
• Search Google Scholar
• Export Citation

Camu F, Beecher T, Recker DP, et al: Valdecoxib, a COX-2-specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty. .Am J Ther 9::43. ,2002. .

• PubMed
Camu F, Beecher T, Recker DP, et al: Valdecoxib, a COX-2-specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty. .Am J Ther9::43. ,2002. .11782819)| false
• Search Google Scholar
• Export Citation

Reynolds LW, Hoo RK, Brill RJ, et al: The COX-2 specific inhibitor, valdecoxib, is an effective, opioid-sparing analgesic in patients undergoing total knee arthroplasty. .J Pain Symptom Manage 25::133. ,2003. .

• PubMed
Reynolds LW, Hoo RK, Brill RJ, et al: The COX-2 specific inhibitor, valdecoxib, is an effective, opioid-sparing analgesic in patients undergoing total knee arthroplasty. .J Pain Symptom Manage25::133. ,2003. .12590029)| false
• Search Google Scholar
• Export Citation

Joshi GP, Viscusi ER, Gan TJ, et al: Effective treatment of laparoscopic cholecystectomy pain with intravenous followed by oral COX-2 specific inhibitor. .Anesth Analg 98::336. ,2004. .

• PubMed
Joshi GP, Viscusi ER, Gan TJ, et al: Effective treatment of laparoscopic cholecystectomy pain with intravenous followed by oral COX-2 specific inhibitor. .Anesth Analg98::336. ,2004. .14742366)| false
• Search Google Scholar
• Export Citation

Gan TJ, Joshi GP, Zhao SZ, et al: Presurgical intravenous parecoxib sodium and follow-up oral valdecoxib for pain management after laparoscopic cholecystectomy surgery reduces opioid requirements and opioid-related adverse effects. .Acta Anaesthesiol Scand 48::1194. ,2004. .

• PubMed
Gan TJ, Joshi GP, Zhao SZ, et al: Presurgical intravenous parecoxib sodium and follow-up oral valdecoxib for pain management after laparoscopic cholecystectomy surgery reduces opioid requirements and opioid-related adverse effects. .Acta Anaesthesiol Scand48::1194. ,2004. .15352969)| false
• Search Google Scholar
• Export Citation

Zhao SZ, Chung F, Hanna DB, et al: Dose-response relationship between opioid use and adverse effects after ambulatory surgery. .J Pain Symptom Manage 28::35. ,2004. .

• PubMed
Zhao SZ, Chung F, Hanna DB, et al: Dose-response relationship between opioid use and adverse effects after ambulatory surgery. .J Pain Symptom Manage28::35. ,2004. .15223083)| false
• Search Google Scholar
• Export Citation

Gan TJ, Joshi GP, Viscusi E, et al: Preoperative parenteral parecoxib and follow-up oral valdecoxib reduce length of stay and improve quality of patient recovery after laparoscopic cholecystectomy surgery. .Anesth Analg 98::1665. ,2004. .

• PubMed
Gan TJ, Joshi GP, Viscusi E, et al: Preoperative parenteral parecoxib and follow-up oral valdecoxib reduce length of stay and improve quality of patient recovery after laparoscopic cholecystectomy surgery. .Anesth Analg98::1665. ,2004. .15155324)| false
• Search Google Scholar
• Export Citation

Jenkins JK, Seligman PJ: Analysis and recommendations for agency action regarding non-steroidal anti-inflammatory drugs and cardiovascular risk [memorandum]. Available at: http://www.fda.gov/cder/drug/infopage/COX2/NSAIDdecisionMemo.pdf. Accessed June 20. ,2005. .

• PubMed
Jenkins JK, Seligman PJ: Analysis and recommendations for agency action regarding non-steroidal anti-inflammatory drugs and cardiovascular risk [memorandum]. Available at: http://www.fda.gov/cder/drug/infopage/COX2/NSAIDdecisionMemo.pdf. Accessed June 20. ,2005. .)| false
• Export Citation